MedPath

Ablation of Sympathetic Atrial Fibrillatio

Not Applicable
Completed
Conditions
<p>Atrial fibrillation, hypertension</p>
10007521
Registration Number
NL-OMON24798
Lead Sponsor
Isala klinieken, department of Cardiology, Zwolle
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
145
Inclusion Criteria

The patient falls within the target group resistent hypertension or symphatic overdrive

Patient is an acceptable candidate for renal denervation treatment

Exclusion Criteria

Contraindication to chronic anticoagulation therapy or heparin

Previous left heart ablation procedure for AF

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Time to first detection of atrial fibrillation (AF) &gt;30 seconds, with the monitoring period starting 3 months after the intervention.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>AF burden after 12 months of follow-up, expressed in % of the monitoring period, in patients with continuous rhythm monitoring. The monitoring period starts 3 months after the intervention. Blood pressure at 3, 6, 12 months after the intervention, and change in blood pressure compared to measurement before the intervention<br /><br>Blood pressure and heart rate response changes induced by exercise testing<br /><br>Changes in heart rate variability measures tested by Holter monitoring compared to measurement before the intervention<br /><br>Changes in arterial stiffness measures post intervention AASI (ambulatory arterial stiffness index) by ambulatory blood pressure monitoring, PWV (pulse wave velovity) and augmentation index compared to measurement before the intervention</p><br>
© Copyright 2025. All Rights Reserved by MedPath